Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
1.
Int J Immunopathol Pharmacol ; 22(2): 371-7, 2009.
Article in English | MEDLINE | ID: mdl-19505391

ABSTRACT

Several studies suggest that microangiopathy plays a crucial role in the pathogenesis of psoriasis. TNFalpha up-regulates the genetic transcription of VEGF, a pro-angiogenetic cytokine over-expressed in psoriatic skin, which promotes micrangiopathic modifications in psoriatic plaque. Etanercept is a chimeric protein used in the treatment of psoriasis and other immunomediated disorders, which blocks inflammatory response by interfering in the binding of TNF-alpha to its receptors. Starting from this data, we retain that etanercept can improve microangiopathy in psoriatic skin by reducing the synthesis of pro-angiogenetic chemokine VEGF. The aims of the study are: to verify the effect of etanercept on cutaneous en plaque capillaries in vivo using intra-vital videocapillaroscopy analysis, to evaluate the relation between the en plaque videocapillaroscopic pattern and the immunohistochemical cutaneous expression of VEGF in psoriasis, and finally to correlate all these in data with clinical disease activity. Eighteen patients (10 male and 8 female, mean age 51, range 21-60) suffering from stable, en plaque type psoriasis, involving at least 10 percent of body surface area (BSA), and not responsive to conventional therapy were included in the study. All the enrolled patients received etanercept 50mg/twice/week, subcutaneously, for 12 weeks, and were carefully followed up for clinical response with PASI score and DLQI index both before (T0) and after 12 weeks (T12) of treatment with etanercept. A well demarcated psoriatic plaque of the extensor surface of upper extremities was chosen to perform an intra-vital videocapillaroscopy analysis (IVCP), and a skin biopsy for immunohistochemical study both at T0 and T12 in all the included patients, in order to evaluate the presence of microangiopathy and its modification after therapy. All the patients experienced a clinical improvement of cutaneous disease with a significant decrease of PASI score (p<0.0001) and DLQI level (p<0.0001), throughout the twelve weeks of treatment. On IVCP analysis, microangiopathy dramatically decreased (p<0.0001), this modification being significantly related with PASI and DLQI decrease at T12. Immunohistochemical expression of VEGF decreased significantly from T0 to T12 (p<0.0001), and was related with a reduction of psoriatic microangiopathy at T12. The results of our videocapillaroscopic and immunohistochemical investigation confirm that the therapeutic potentiality of etanercept is based also on its capability to promote the regression of psoriatic microangiopathy. Moreover, according to these considerations, videocapillaroscopic evaluation of psoriatic plaque, both before and after treatment with etancercept, may be a useful tool to objectively demonstrate its effect on microcirculation.


Subject(s)
Angiogenesis Inhibitors/administration & dosage , Immunoglobulin G/administration & dosage , Immunohistochemistry , Immunosuppressive Agents/administration & dosage , Microscopy, Video , Neovascularization, Pathologic/prevention & control , Psoriasis/drug therapy , Receptors, Tumor Necrosis Factor/administration & dosage , Skin/drug effects , Adult , Capillaries/drug effects , Capillaries/pathology , Etanercept , Female , Humans , Injections, Subcutaneous , Male , Middle Aged , Neovascularization, Pathologic/metabolism , Psoriasis/metabolism , Psoriasis/pathology , Severity of Illness Index , Skin/blood supply , Skin/pathology , Time Factors , Treatment Outcome , Vascular Endothelial Growth Factor A/metabolism , Young Adult
2.
Burns ; 39(6): 1178-83, 2013 Sep.
Article in English | MEDLINE | ID: mdl-23579036

ABSTRACT

INTRODUCTION AND AIM: Several studies have demonstrated that ozonated oil is effective on cutaneous wound healing. This in vivo study has been conducted to evaluate the clinical effect of the topical application of ozonated oil for 12 weeks on second-degree skin burns. METHOD: A total of 30 patients suffering from second-degree skin burns in the phase of re-epithelisation were included in this study. Every skin burn was subdivided in two symmetrical parts. One part was treated with occlusive application of ozonated oil; the contralateral part of the lesion was treated with topical application of hyaluronic acid gel, once a day for 12 weeks. A clinical evaluation and an intra-vital video-capillaroscopy were performed on every patient at baseline, 6 and 12 weeks after. RESULTS: All treated lesions improved regardless of the treatment used. Ozonated oil was as effective as hyaluronic acid in improving erythema, tension, itching and burning sensation reported by patients, and it does not exert a specific anti-angiogenic effect compared to hyaluronic acid. However it seems more effective than hyaluronic acid in reducing post-lesional hyperpigmentation. CONCLUSION: Ozonated oil, topically applied for 12 weeks, seems to be as effective as hyaluronic acid in reducing symptoms related to skin burns, but it could be more effective in preventing the post-lesional hyperpigmentation.


Subject(s)
Burns/drug therapy , Hyaluronic Acid/administration & dosage , Oils/administration & dosage , Oxidants, Photochemical/administration & dosage , Ozone/administration & dosage , Wound Healing/drug effects , Administration, Topical , Adult , Aged , Burns/pathology , Female , Gels/administration & dosage , Humans , Hyperpigmentation/prevention & control , Male , Microcirculation/drug effects , Middle Aged , Prospective Studies , Single-Blind Method , Skin/blood supply , Skin/drug effects
3.
Stomatol Mediterr ; 8(3): 205-10, 1988.
Article in Italian | MEDLINE | ID: mdl-3274158

ABSTRACT

Among the various cases of etherotophy, the only and multiple, that has observed, the Authors consider only a few among the significant ones and with endosinusal localization-after examining the probable mechanism patogenetic we pay attention to the necessity of an exact diagnostic judgement and on the opportunity of a precocious and exact treatment.


Subject(s)
Paranasal Sinus Diseases , Tooth Eruption, Ectopic , Adolescent , Female , Humans , Male , Tooth, Impacted
SELECTION OF CITATIONS
SEARCH DETAIL